ATH 16.7% 0.4¢ alterity therapeutics limited

A new low before the new year... They categorized the warrant...

  1. 516 Posts.
    lightbulb Created with Sketch. 13
    A new low before the new year... They categorized the warrant expiration as a non price sensitive issue. That means they believe their operation is not influenced by whether Life Biosciences give them the money or not. If they deliver wrong messages to the market, can we sue them? I hope they are really ready to carry out a P2 trial with what they have now.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.